Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Otsuka Holdings (4578 JP)
Watchlist
182
Analysis
Health Care
•
Japan
Otsuka Holdings Co Ltd is a pharmaceutical company. The Company manufactures, sells, imports and exports pharmaceuticals, clinical testing, and medical equipment for intractable diseases.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Thematic (Sector/Industry)
•
12 Mar 2017 15:15
The Week That Was in NorthAsia@Smartkarma
This is the second report of "The Week That Was in North Asia@Smartkarma". This is a collaborative report among Travis Lundy, Mio Kato, CFA,...
Travis Lundy
Follow
433 Views
Share
bullish
•
Thematic (Sector/Industry)
•
04 Mar 2017 11:12
The Week That Was in NorthAsia@Smartkarma - Jelly Drinks, Dental Implants, & Tires
This is the inaugural report of "The Week That Was in North Asia@Smartkarma. This is a collaborative report among Travis Lundy, Mio Kato, CFA,...
Douglas Kim
Follow
446 Views
Share
bullish
•
Sumitomo Pharma
•
21 Apr 2026 10:02
Sumitomo Pharma (4506 JP): Placement Is In Line With “Boost 2028” Plan, R&D in Focus
Sumitomo Pharma announced the placement price to be ÂĄ1990 per share. Net proceeds of ÂĄ111.6B yen is expected to be used for R&D in oncology (~...
Tina Banerjee
Follow
270 Views
Share
bullish
•
Thematic (Sector/Industry)
•
30 Jan 2017 13:50
Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
AML represents one of the largest hematologic cancer populations with one of the worst survival rates. Global prevalence is expected to increase at...
Dion Stéfan Büchner M.D., FCAP
643 Views
Share
bullish
•
Thematic (Sector/Industry)
•
13 Dec 2016 11:44
American Society of Hematology- (ASH) Annual Conference (2016) Review
We reviewed data presented at the American Society of Hematology (ASH) conference in San Diego last week with a focus on the evolving treatment...
Dion Stéfan Büchner M.D., FCAP
526 Views
Share
First
Previous
14
15
16
17
18
19
20
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x